Skip to content

Low-frequency electromagnetic pulse therapeutic apparatus for treating diabetes (Qi and Yin deficiency syndrome) Safety and efficacy, a random, self-controlled, multi-center clinical trial

Low-frequency electromagnetic pulse therapeutic apparatus for treating diabetes (Qi and Yin deficiency syndrome) Safety and efficacy, a random, self-controlled, multi-center clinical trial

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR-ONC-16009435
Enrollment
Unknown
Registered
2016-10-15
Start date
2010-03-01
Completion date
Unknown
Last updated
2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

diabetes

Interventions

Low-frequency electromagnetic pulse therapeutic apparatus therapy group:Low-frequency electromagnetic stimulation therapy

Sponsors

Affiliated Hospital of Inner Mongolia Medical University
Lead Sponsor

Eligibility

Sex/Gender
Male
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: Have been diagnosed with diabetes,type1, type2 patients.

Exclusion criteria

Exclusion criteria: 1. Although blood glucose is higher than normal, but test the import stage through diet control, increased activity, etc., to decrease blood glucose testing diagnostic value or less; 2. Nearly a month by the diabetic ketoacidosis and other acute metabolic disorders and concurrent infection; 3. Pregnant or lactating women, during the test does not guarantee contraception for women; 4. Severe allergies or skin allergies electromagnetic stimulation; 5. Diabetic patient inflammation and ulceration of the foot infection; 6. An autoimmune disease or any serious fatal disease; 7. Mental disorders, without self-control, not the exact expression; 8. Critical condition, difficult to make the right evaluator; 9. Clinicians believe not suitable to participate in this test.

Design outcomes

Primary

MeasureTime frame
TCM syndrome score ratings;Fasting blood glucose, urine glucose;

Secondary

MeasureTime frame
Blood lipid, hemorheology;

Countries

China

Contacts

Public ContactChang Hong

Affiliated Hospital of Inner Mongolia Medical University

Niji5618@vip.sina.com+86 13847158886

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026